Stay updated with the latest radiopharmaceutical news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on radiopharmaceutical topics.
Chennai: India's fast breeder reactor programme achieved twin milestones this week. The Fast Breeder Test Reactor (FBTR) at the Indira Gandhi Centre for Atomic Research (IGCAR), Kalpakkam, marked 40 years of attaining first criticality. Meanwhile, engineers began loading fuel into the Prototype Fast Breeder Reactor (PFBR), the country's most advanced and complex atomic power plant.Officials said the Atomic Energy Regulatory Board (AERB) recently granted permission for fuel loading into the 500 M ...Read More >
CHENNAI: The Indira Gandhi Centre for Atomic Research (IGCAR), Kalpakkam, the second largest R&D establishment under the Department of Atomic Energy (DAE), celebrated the 40th anniversary of the First Criticality of the Fast Breeder Test Reactor (FBTR) on Saturday, with a special commemorative event highlighting decades of innovation, self-reliance and technological excellence in nuclear energy. Achieving its first criticality in 1985, FBTR has been a flagship of the country's indigenous fast r ...Read More >
Chennai: India's fast breeder reactor programme achieved twin milestones this week. The Fast Breeder Test Reactor (FBTR) at the Indira Gandhi Centre for Atomic Research (IGCAR), Kalpakkam, marked 40 years of attaining first criticality. Meanwhile, engineers began loading fuel into the Prototype Fast Breeder Reactor (PFBR), the country's most advanced and complex atomic power plant.Officials said the Atomic Energy Regulatory Board (AERB) recently granted permission for fuel loading into the 500 M ...Read More >
MELBOURNE, Australia, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces it will expand its theranostic pipeline with new assets targeting Fibroblast Activation Protein (FAP), one of the most promising pan-cancer targets in nuclear medicine. Telix's development program will initially focus on the treatment of bladder cancer, rounding out its urology franchise, which includes late-stage therapeutic programs for kidney and pr ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.